Please try another search
For the nine months ended 30 September 2021, Soc Telemed Inc revenues increased from $0K to $66.5M. Net loss applicable to common stockholders increased from $2.5M to $37.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.08 to -$0.44.
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Revenue | 26.68 | 24.96 | 14.82 | 57.99 |
Gross Profit | 8.12 | 8.02 | 5.15 | 19.45 |
Operating Income | -12.81 | -11.51 | -16.21 | -39 |
Net Income | -10.65 | -14.46 | -12.6 | -48.93 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Total Assets | 273.62 | 288.52 | 272 | 84.94 |
Total Liabilities | 95.41 | 102.36 | 126.67 | 29.87 |
Total Equity | 178.21 | 186.17 | 145.33 | 55.07 |
Period Ending: | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -28.17 | -18.04 | -7.89 | -22.58 |
Cash From Investing Activities | -94.39 | -92.52 | -93.05 | -6.53 |
Cash From Financing Activities | 121.54 | 121.81 | 94.72 | 63.32 |
Net Change in Cash | -1.03 | 11.25 | -6.22 | 34.21 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review